Staphylococcus aureus bacteraemia at two academic hospitals in Johannesburg

South African Medical Journal

Volumn 96, Issue 8, 2006, Pages 714-717

  Perovic, Olga ^a   Koornhof, Hendrik ^a   Black, Vivian ^a   Moodley, Indres ^b   Duse, Adrian ^a   Galpin, Jacky ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; METICILLIN; OFLOXACIN; OXACILLIN; RIFAMPICIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL STRAIN; BLOOD CULTURE; BURN; COMMUNICABLE DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE PREDISPOSITION; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; MEDICAL RECORD REVIEW; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; NONHUMAN; PREDICTION; RISK FACTOR; SOUTH AFRICA; STAPHYLOCOCCUS AUREUS; TIME; UNIVERSITY HOSPITAL;

ADULT; BACTEREMIA; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; MALE; METHICILLIN RESISTANCE; RETROSPECTIVE STUDIES; RISK FACTORS; SOUTH AFRICA; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 33748349190     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998; 339: 520-532.
2. Myllotte JM, Yayara A. Staphylococcus aureus bacteremia: predictors of 30-day mortality in a large cohort. Clin Infect Dis 2000; 31: 1170-1174.
3. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteraemia: A meta-analysis. Clin Infect Dis 2003; 36: 53-59.
4. Whitby M, McLaws ML, Berry G. Risk of death from methicillin-resistant Staphylococcus aureus bacteraemia: a metaanalysis. Med J Aust 2001; 175: 264-267.
5. Fowler VG, Sexton DJ. Epidemiology and risk factors for bacteremia due to Staphylococcus aureus infection. Up to Date 2001 9.3 CD ROM last updated August 2000.
6. Boyce JM, Havill NL, Kohan S, Dumingan DG, Ligi DE. Do infection control measures work for methicillin-resistant Staphylococcus, aureus? Infect Control Hosp Epidemiol 2004; 25: 395-401.
7. Daum RS, Ito T, Hiramatsu K, et al. A novel methicillin-resistance cassette in community-acquired methicillin-resistant Staphylococcus aureus isolates of diverse genetic backgrounds. J Infect Dis 2002; 186: 1344-1347.
8. Hiramatsu K, Hanaki H, Ini T, Yabuta K, Oguri T, Tenover FC. Methicillin resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 1997; 40: 135-146.
9. Ferraz V, Duse A, Black AD, Kassel M, Ito T, Hiramatsu K. Glycopeptide-intermediate Staphylococcus aureus occurs in South Africa. S Afr Med J 2000; 90: 113.
10. Wang CC, Lo WT, Chu ML, Siu LK. Epidemiological typing of community-acquired methicillin-resistant Staphylococcus aureus isolates from children in Taiwan. Clin Infect Dis 2004; 39: 481-487.
11. Ibrahim EH, Sherman G, Fraser VJ, Kollef MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000; 118: 146-155.
12. Vergis EN, Hayden MK, Chow JW, et al. Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia, a prospective multicenter study. Ann Intern Med 2001; 135: 484-492.
13. Nathwani D. Impact of methicillin-resistant Staphylococcus aureus infections on key health economic outcomes: does reducing the length of hospital stay matter? J Antimicrob Chemother 2003; 51: Suppl. S2, ii37-ii44.
14. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. Fifteenth Informational Supplement. M100-515. 2005; 25: 44-51.
15. Harbarth S, Rutschmann O, Sudre P, Pittet D. Impact of methicillin resistance on the outcome of patients with bacteraemia caused by Staphylococcus aureus. Arch Intern Med 1998; 158: 182-189.
16. Naimi TS, LeDell KH, Como-Sabetti K, et al. Comparison of community and health care-associated methicillin-resistant Staphylococcus aureus. Infection JAMA 2003; 290: 2976-2984.
17. Tumbarello M, Donati KG, Tacconelli E, et al. Risk factors and predictors of mortality of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in HIV-infected patients. J Antimicrob Chemother 2002; 50: 375-382.